Journal
ATHEROSCLEROSIS
Volume 210, Issue 1, Pages 177-182Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.atherosclerosis.2009.11.029
Keywords
SCARB1; SR-BI; HDL; Atherosclerosis; Synonymous; SNPs
Funding
- NIH NHLBI [HL075646]
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075646] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Objective: A synonymous variant within scavenger receptor class B type I gene (SCARB1), exon 8 rs5888, has been associated with altered lipid levels and cardiovascular risk in humans. The objective was to determine if rs5888 decreased SR-BI protein expression and function in vitro. Methods: SR-BI RNA secondary structure, turnover, polysomal distribution and protein expression were examined in COS cells transfected with wild-type or rs5888-SR-BI plasmids by selective 2'-hydroxyl acylation and primer extension assays, actinomycin D inhibition, polysomal pro. ling, and western blotting. SR-BI function in murine macrophages stably expressing wild-type or rs5888-SR-BI was assessed by measuring the specific cell association of (125)I,(3)H-cholesteryl ester (CE) radiolabeled HDL. Results: Rs5888 changed RNA secondary structure and led to marked differences in the polysomal profiles compared with wild-type transcript (p < 0.02). As compared to wild-type cells, COS cells expressing rs5888 had significantly lower SR-BI protein expression (p < 0.04), but no difference in total RNA transcript levels. There were no differences in SR-BIRNA turnover in murine macrophages, whereas specific cell association of (125)I (p < 0.0001) or (3)H-CE (p < 0.00001) was significantly lower in rs5888 cells. Conclusions: The rs5888 variant affected SR-BI RNA secondary structure, protein translation, and was significantly associated with reduced SR-BI protein expression and function in vitro. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available